Menu
Search
|

Menu

Close
X

Sanofi SA SASY.PA (Paris Stock Exchange)

79.53 EUR
-0.24 (-0.30%)
As of Sep 13
Previous Close 79.77
Open 79.63
Volume 2,796,760
3m Avg Volume 2,336,647
Today’s High 80.02
Today’s Low 77.85
52 Week High 82.11
52 Week Low 71.74
Shares Outstanding (mil) 1,252.02
Market Capitalization (mil) 96,365.35
Forward P/E 26.94
Dividend (Yield %) 3.07 ( 3.93 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.12 Mean rating from 24 analysts

KEY STATS

Revenue (mm, EUR)
FY19
17,693
FY18
45,421
FY17
45,617
FY16
43,991
EPS (EUR)
FY19
0.842
FY18
5.267
FY17
4.167
FY16
4.679
*Note: Units in Millions of Euro
**Note: Units in Euro

KEY RATIOS

Price to Earnings (TTM)
vs sector
26.94
33.85
Price to Sales (TTM)
vs sector
2.62
7.90
Price to Book (MRQ)
vs sector
1.71
4.38
Price to Cash Flow (TTM)
vs sector
17.85
23.70
Total Debt to Equity (MRQ)
vs sector
47.37
17.64
LT Debt to Equity (MRQ)
vs sector
39.12
12.61
Return on Investment (TTM)
vs sector
3.38
12.69
Return on Equity (TTM)
vs sector
6.38
17.13

EXECUTIVE LEADERSHIP

Serge Weinberg
Independent Chairman of the Board, Since 2015
Salary: €700,000.00
Bonus: --
Olivier Brandicourt
Chairman of the Executive Committee, Chief Executive Officer, Director, Since 2015
Salary: €1,200,000.00
Bonus: €1,792,800.00
Jean-Baptiste Chasseloup de Chatillon
Chief Financial Officer, Executive Vice President, Member of the Executive Committee, Since 2018
Salary: --
Bonus: --
Karen Linehan
Executive Vice President - Legal Affairs and General Counsel, Member of the Executive Committee, Since 2014
Salary: --
Bonus: --
Caroline Luscombe
Executive Vice President of Human Resources, Member of the Executive Committee, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

54 rue la Boetie
PARIS     75008

Phone: +331.53774000

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.

SPONSORED STORIES